Icotinib hydrochloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Icotinib hydrochloride, covering 2014-11-05 to 2023-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy [Phase 2]